SCHEMBL27762010

SCHEMBL27762010

CC(C=O)c1ccccc1N1CCN(C)CC1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRA2C P18825 1/20 0.49
KMT2A Q03164 2/20 0.48
EGFR P00533 1/20 0.48
LMNA P02545 1/20 0.48
MAPT P10636 1/20 0.48
MAPK1 P28482 1/20 0.48
DRD3 P35462 5/20 0.46
DRD2 P14416 5/20 0.46
HTR1A P08908 2/20 0.42
HTR2C P28335 2/20 0.42
DRD4 P21917 1/20 0.42
HTR2A P28223 1/20 0.42
NCF1 P14598 1/20 0.41
HTR6 P50406 3/20 0.41
ALDH1A1 P00352 1/20 0.40
HDAC3 O15379 1/20 0.39
HDAC4 P56524 1/20 0.39
HDAC1 Q13547 1/20 0.39
HDAC7 Q8WUI4 1/20 0.39
HDAC2 Q92769 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27536638 0.83 L3MBTL1 (0.47) KMT2ALMNAMAPTALDH1A1MEN1
SCHEMBL13006367 0.81 ADRA2C (0.56) ADRA2CKMT2AEGFRLMNAMAPT
SCHEMBL27741259 0.79 POLB (0.54) LMNAMAPTHTR6ALDH1A1
SCHEMBL27762008 0.77 ADRA2C (0.49) ADRA2CKMT2AEGFRLMNAMAPT
SCHEMBL27760543 0.76 ADRA2C (0.55) ADRA2CKMT2AEGFRLMNAMAPT
SCHEMBL2113196 0.75 ADRA2C (0.50) ADRA2CKMT2AEGFRLMNAMAPT
SCHEMBL27741262 0.74 CHRNA7 (0.47) DRD3DRD4HTR6ALDH1A1HDAC3
SCHEMBL24227168 0.73 ADRA2C (0.47) ADRA2CKMT2AEGFRLMNAMAPT
SCHEMBL20376817 0.73 ADRA2C (0.51) ADRA2CKMT2AEGFRLMNAMAPT
SCHEMBL16019523 0.73 FAAH (0.52) ADRA2CMAPTDRD2HTR1AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101448802-B Acrylamide derivative as histone deacetylase inhibitors for cancer treatment DAC SRL 2012-11-07 CN disclosed
CN-101448802-A N-hydroxy-3-(4-{3-phenyl-S-oxo-propenyl}-phenyl)-acrylamide derivatives and related compounds as histone deacetylase inhibitors for the treatment of cancer DAC SRL (IT) 2009-06-03 CN disclosed